Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000182

Director sold 10,111 shares at an average $73.51 ($743,238)

  • Director acquired 10,111 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KLEIN JOSEPH III Director 2026-05-01 Option exercise 10b5-1 +10,111 $47.11 $476,329 21,125 D: show line 1 in the form
KLEIN JOSEPH III Director 2026-05-01 Sale 10b5-1 −8,680 $73.35 $636,704 12,445 D: show line 2 in the form
KLEIN JOSEPH III Director 2026-05-01 Sale 10b5-1 −1,431 $74.45 $106,534 11,014 D: show line 3 in the form
Open-market sales · 10,111 sh · avg $73.51 · $743,238

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KLEIN JOSEPH III Director 2026-05-01 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −10,111 0 D: show line 4 in the form
Loading xslF345X06/edgardoc.xml…